Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00394602 · ClinicalTrials.gov registry record
Chemoradiation-Induced Nausea and Emesis: Quality of Life
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 207
- Enrollment target
NCT00394602: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT00394602 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 207 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00394602 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 207 participants
- Enrollment target
Study Summary
The primary objectives of this study are: 1. To assess the preferences of cancer patients scheduled to receive chemoradiation and caregiver controls for side-effects of chemoradiation. 1. To compare preferences of cancer patients to those of healthy individuals. 2. To compare how patients' preferences for side-effects of chemoradiation change over time. 2. To longitudinally assess the quality of life of cancer patients scheduled to receive chemoradiation. 3. To determine the impact of nausea and vomiting associated with chemoradiation on patients' quality of life and evaluate potential change throughout the duration of chemoradiation treatment.
Primary Outcome
Quality of life survey instruments scored according to EORTC QLQ-C30 scoring manual. Patients and controls compared with respect to preference data. The control group preference data collected at only 1 time point, but patient preference data from each time point will be compared to these control group preference data.
Interventions
- OTHER Questionnaire
- BEHAVIORAL Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2004-04-07 |
| Est. Completion | 2019-05-08 |
Why NCT00394602 stopped before completion
NCT00394602 is an observational study that tracks outcomes without assigning an intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT00394602 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00394602 about?
NCT00394602 is a clinical study titled "Chemoradiation-Induced Nausea and Emesis: Quality of Life". The primary objectives of this study are: 1. To assess the preferences of cancer patients scheduled to receive chemoradiation and caregiver controls for side-effects of chemoradiation. 1. To compare preferences of cancer patients to those of healthy individuals. 2. To compare how patients' p...
What is the current status of trial NCT00394602?
This trial is currently terminated. The enrollment target is 207 participants. The study started on 2004-04-07. Estimated completion is 2019-05-08.
What interventions are being tested in trial NCT00394602?
The interventions under investigation include: Questionnaire (OTHER), Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT00394602?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04353778 · 207 participants · Phase 1
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
- NCT05875805 · 207 participants · NA
A Telehealth Advance Care Planning Intervention
- NCT06254950 · 207 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
- NCT06904274 · 207 participants · Phase 3
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI